Clinical trials
Phase 2 Movement Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Terminated | 2 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Jazz Pharmaceuticals | 3 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 3 |
| Praxis Precision Medicines | 3 |
| Alterity Therapeutics | 2 |
| Joshua Woolley, MD, PhD | 2 |
| Alkahest, Inc. | 1 |
| Andrew Newberg | 1 |
| Bial R&D Investments, S.A. | 1 |
| Denali Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Movement Disorders | 33 |
| Parkinson Disease | 21 |
| Central Nervous System Diseases | 8 |
| Neurodegenerative Diseases | 8 |
| Dyskinesias | 7 |
| Parkinsonian Disorders | 7 |
| Essential Tremor | 6 |
| Nervous System Diseases | 4 |
| Tremor | 4 |
| Basal Ganglia Diseases | 3 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.